The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro

The transcription factor NF-κB has a central role in cellular stress and inflammatory responses by controlling cytokine-inducible gene expression and lymphocyte stimulation by antigens (Baeuerle and Baltimore 1996; Gilmore et al. 1996). In addition, NF-κB is required to block cell death in response to tumor necrosis factor α (TNFα) and ionizing radiation, suggesting that it acts to regulate the transcription of survival genes (Beg and Baltimore 1996; Liu et al. 1996; Van Antwerp et al. 1996; Wang et al. 1996). NF-κB is a ubiquitous heterodimeric complex composed of a p65/RelA subunit and a p50 subunit. This complex is normally sequestered in an inactive form in the cytoplasm through interaction with members of a family of inhibitory proteins, the IκBs (Beg et al. 1992; for review, see Baeuerle and Baltimore 1996). These proteins, when associated with NF-κB, obscure the nuclear localization signal in NF-κB and also block the ability of NF-κB to bind DNA. In response to TNFα and other signals, IκBα is rapidly phosphorylated on two serine residues near the amino terminus (Ser-32 and Ser-36 in IκBα) (Beg et al. 1993; Finco et al. 1994; Alkalay et al. 1995; Brown et al. 1995; Chen et al. 1995, 1996; DiDonato et al. 1995; Lin et al. 1995). This modification triggers the rapid destruction of IκBα by ubiquitin-mediated proteolysis, thereby allowing NF-κB nuclear translocation and target gene expression (Chen et al. 1995; Scherer et al. 1995; for review, see Hochstrasser 1996). Recent work has uncovered two IκBα kinases, IκKα and IκKβ, that are responsible for signal-dependent phosphorylation of IκBα (DiDonato et al. 1997; Mercurio et al. 1997; Regnier et al. 1997; Woronicz et al. 1997; Zandi et al. 1997, 1998). These proteins are part of a 700-kD protein complex that is assembled through two structural components IκKγ/NEMO and IKAP (Cohen et al. 1998; Rothwarf et al. 1998; Yamaoka et al. 1998) and are activated by cytokines. In vitro, both IκKα and IκKβ can phosphorylate IκBα specifically on serines 32 and 36, but both kinases are required for efficient IκBα phosphorylation in vivo (Zandi et al. 1997). Although the pathways leading to IκBα phosphorylation have been described in detail, little is known about the molecules responsible for ubiquitination. Ubiquitin-mediated proteolysis involves a cascade of ubiquitin transfer reactions in which the ubiquitin-activating enzyme E1 uses ATP to form a high-energy thiolester bond with ubiquitin, which is then transferred to members of the E2 ubiquitin-conjugating enzyme family (Hershko et al. 1983; Hochstrasser 1995). Ubiquitin is then transferred from the E2 to lysine residues in the target through an E3–ubiquitin ligase. E3s serve as adaptors that interact with both the target protein and the appropriate E2, thereby providing specificity to the ubiquitin transfer reaction. In some cases, the E3 is also involved in ubiquitin transfer (Scheffner et al. 1995; Rolfe et al. 1995). Multiple rounds of ubiquitination of the initial conjugates lead to polyubiquitination, which targets the protein for proteolysis by the 26S proteasome. Recent studies have elaborated a modular ubiquitin ligase complex, the SCF–ubiquitin ligase, which mediates phosphorylation-dependent ubiquitination of a large number of proteins (for review, see Elledge and Harper 1998; Patton et al. 1998b). The SCF is composed of Skp1, Cdc53/Cul1, and a specificity-conferring F-box protein (Bai et al. 1996; Feldman et al. 1997; Skowyra et al. 1997; Patton et al. 1998a). F-box proteins contain two domains, an F-box motif that binds Skp1 and allows assembly into Skp1/Cdc53 complexes, and a second protein–protein interaction domain that interacts specifically with one or more target proteins (Bai et al. 1996). Cdc53/Cul1, in turn, interacts with both the E2 and the Skp1/F-box protein complex (Skowyra et al. 1997; Patton et al. 1998a). SCF complexes mediate phosphorylation-dependent destruction of a wide array of regulatory proteins in yeast, including the Cdk inhibitors Sic1, Far1, and Rum1, G1 cyclins, the transcription factor Gcn4, and the DNA replication initiator proteins Cdc6 and Cdc18 (for review, see Elledge and Harper 1998; Patton et al. 1998b). In contrast with yeast, targets of vertebrate SCF complexes remain largely unknown. Previously, we identified four vertebrate proteins that contain the F-box motif, linking them to the ubiquitin pathway: mammalian cyclin F, Skp2, MD6, and Xenopus β-TRCP (β-transducin repeat-containing protein; Bai et al. 1996). β-TRCP was originally identified as a suppressor of a temperature-sensitive mutation in the budding yeast CDC15 gene (Spevak et al. 1993), but its mechanism of suppression has not been determined. Recent genetic evidence has implicated Xenopus β-TRCP and its Drosphila homolog, slimb, in control of proteolysis in the Hedgehog and Wingless/Wnt signaling pathways (Jiang and Struhl 1998; Marikawa and Elinson 1998). We have used biochemical approaches to examine whether IκBα ubiquitination might involve an SCF–ubiquitin ligase. Here we report that mammalian β-TRCP binds to the IκBα destruction motif in a phosphorylation-dependent manner, thereby recruiting IκBα into an SCF–ubiquitin ligase complex. Moreover, SCFβ-TRCP components cofractionate with IκBα–ubiquitin ligase activity from tissue culture cells and SCFβ-TRCP can stimulate ubiquitination of phosphorylated but not unphosphorylated IκBα in an in vitro reconstitution assay. We also demonstrate that the same SCFβ-TRCP complex recognizes a similar destruction motif in β-catenin, a component of the TCF/Lef transcription factor complex that functions downstream of Wingless/Wnt (for review, see Peifer 1997) and whose levels are also controlled by phosphorylation-dependent ubiquitin-mediated proteolysis (Aberle et al. 1997). Our results, together with the effects of loss-of-function mutations in the Drosophila β-TRCP homolog slimb (Jiang and Struhl 1998), suggest that a single SCFβ-TRCP complex functions in diverse signaling pathways that impinge on transcription control mediated by cytokines (NF-κB), Wnt/Wingless (β-catenin), and Hedgehog [Cubitus interruptus (Ci)].

[1]  M. Pagano,et al.  The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin , 1999, Oncogene.

[2]  Stephen J. Elledge,et al.  The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes , 1998, Current Biology.

[3]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.

[4]  E. Zandi,et al.  IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.

[5]  P. Baeuerle,et al.  IKAP is a scaffold protein of the IκB kinase complex , 1998, Nature.

[6]  Y. Marikawa,et al.  β-TrCP is a negative regulator of the Wnt/β-catenin signaling pathway and dorsal axis formation in Xenopus embryos , 1998, Mechanisms of Development.

[7]  Ebrahim Zandi,et al.  Direct Phosphorylation of IκB by IKKα and IKKβ: Discrimination Between Free and NF-κB-Bound Substrate , 1998 .

[8]  G. Courtois,et al.  Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.

[9]  R. Deshaies,et al.  Human CUL1 forms an evolutionarily conserved ubiquitin ligase complex (SCF) with SKP1 and an F-box protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Gelmann,et al.  β-Catenin Mutations in Human Prostate Cancer , 1998 .

[11]  M. Tyers,et al.  Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. , 1998, Trends in genetics : TIG.

[12]  Y. Xiong,et al.  Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  C. Scheidereit,et al.  Signal-dependent degradation of IκBα is mediated by an inducible destruction box that can be transferred to NF-κB, Bcl-3 or p53 , 1998 .

[14]  M. Hochstrasser There's the rub: a novel ubiquitin-like modification linked to cell cycle regulation. , 1998, Genes & development.

[15]  T. Sugimura,et al.  High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. , 1998, Cancer research.

[16]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[17]  D. Thomas,et al.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.

[18]  M. Tyers,et al.  Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast. , 1998, Genes & development.

[19]  G. Struhl,et al.  Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb , 1998, Nature.

[20]  M. Gstaiger,et al.  Association of human CUL‐1 and ubiquitin‐conjugating enzyme CDC34 with the F‐box protein p45SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34–SCF pathway , 1998, The EMBO journal.

[21]  A. Ciechanover,et al.  Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase , 1997 .

[22]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[23]  Mike Rothe,et al.  IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .

[24]  Mike Tyers,et al.  F-Box Proteins Are Receptors that Recruit Phosphorylated Substrates to the SCF Ubiquitin-Ligase Complex , 1997, Cell.

[25]  R. Deshaies,et al.  A Complex of Cdc4p, Skp1p, and Cdc53p/Cullin Catalyzes Ubiquitination of the Phosphorylated CDK Inhibitor Sic1p , 1997, Cell.

[26]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[27]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[28]  R. Deshaies,et al.  SIC1 is ubiquitinated in vitro by a pathway that requires CDC4, CDC34, and cyclin/CDK activities. , 1997, Molecular biology of the cell.

[29]  D. Goeddel,et al.  Identification and Characterization of an IκB Kinase , 1997, Cell.

[30]  Jörg Stappert,et al.  β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .

[31]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[32]  Mark Peifer,et al.  β-Catenin as Oncogene--The Smoking Gun , 1997, Science.

[33]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[34]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[35]  M. Memo,et al.  Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation , 1996, Science.

[36]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[37]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[38]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[39]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[40]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[41]  D. White,et al.  Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.

[42]  Stephen J. Elledge,et al.  SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-Box , 1996, Cell.

[43]  M. Hochstrasser,et al.  Protein Degradation or Regulation: Ub the Judge , 1996, Cell.

[44]  T. Maniatis,et al.  Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.

[45]  T. Maniatis,et al.  Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Ciechanover,et al.  Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Maniatis,et al.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.

[48]  P. Beer-Romero,et al.  Reconstitution of p53-ubiquitinylation reactions from purified components: the role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Gerstberger,et al.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.

[50]  M. Karin,et al.  Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B , 1995, Molecular and cellular biology.

[51]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[52]  Martin Scheffner,et al.  Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade , 1995, Nature.

[53]  M. Kirschner,et al.  Ubiquitination of the G1 cyclin Cln2p by a Cdc34p‐dependent pathway. , 1995, The EMBO journal.

[54]  M. Hochstrasser Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. , 1995, Current opinion in cell biology.

[55]  A. Baldwin,et al.  Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  C. Stratowa,et al.  Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with beta-transducin repeats , 1993, Molecular and cellular biology.

[57]  A. Baldwin,et al.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation , 1993, Molecular and cellular biology.

[58]  S. Ruben,et al.  Erratum: IKB interacts with the nuclear localization sequences of the subunits of NF-KB: A mechanism for cytoplasmic retention (Genes and Development (1992) 6 (1899-1913)) , 1992 .

[59]  S. Ruben,et al.  I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. , 1992, Genes & development.

[60]  A. Friedman,et al.  Loss of heterozygosity for 10q loci in human gliomas , 1992, Genes, chromosomes & cancer.

[61]  F. Mitelman,et al.  Cytogenetic analysis of 57 primary prostatic adenocarcinomas , 1992, Genes, chromosomes & cancer.

[62]  P. Nowell,et al.  Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia. , 1988, Cancer genetics and cytogenetics.